For the Culture By The Culture. ISSN: 3064-9331.
The Washington Post told readers that people with greater lifetime cannabis exposure slept less. But a Northwestern study found no significant link between cumulative use and shorter sleep, while recent users averaged nearly 20 minutes more. Pot Culture Magazine examines the missing context, seven-day sleep monitoring, conflicting scientific reviews, and the newspaper's unanswered fact-checking questions.
Cannabis hyperemesis syndrome is real, but the latest “scromiting” panic outruns the CDC data behind it. Pot Culture Magazine examines a new CHS diagnosis code, 199,565 emergency visits, a combined 15-to-24 age group, and the difference between a documented medical burden and an alarmist headline that turns hospital records into a teen weed emergency.
A new cannabis study claims marijuana does nothing for anxiety, depression, or PTSD. The reality is far more complicated. Decades of federal restrictions, limited research access, and synthetic substitutes have shaped the science. This breakdown exposes how incomplete data and selective interpretation continue to drive misleading headlines about cannabis and mental health.
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
A new study claims cannabis can be measured like alcohol using weekly limits and risk tiers. This feature dismantles that framework, exposing how alcohol math distorts cannabis science, ignores human biology, and fuels modern prohibition under the guise of public health. Numbers may comfort regulators, but they do not reflect reality.
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.